L

LivaNova PLC
D

LIVN

47.450
USD
-0.53
(-1.10%)
مغلق
حجم التداول
12,695
الربح لكل سهم
2
العائد الربحي
-
P/E
110
حجم السوق
2,576,574,621
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ABT
    ABT
    1.785
    (1.34%)
    134.950 USD
    BDX
    BDX
    -0.590
    (-0.26%)
    227.450 USD
    BSX
    BSX
    -0.840
    (-0.80%)
    104.480 USD
    COO
    COO
    -0.180
    (-0.20%)
    88.490 USD
    EW
    EW
    -1.380
    (-1.85%)
    73.300 USD
    ISRG
    ISRG
    -15.37
    (-2.53%)
    591.50 USD
    MDT
    MDT
    2.000
    (2.27%)
    89.940 USD
    SYK
    SYK
    -3.72
    (-0.96%)
    382.74 USD
    TMO
    TMO
    -5.71
    (-1.06%)
    532.28 USD
    ZBH
    ZBH
    1.250
    (1.21%)
    104.890 USD
    المزيد
الأخبار
المقالات

العنوان: LivaNova PLC

القطاع: Healthcare
الصناعة: Medical Devices
UK-based LivaNova was born of a combination between Cyberonics in the us and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. It derives roughly half of its revenue from the us market, another 21% from Europe, and the remainder from the rest of the world.